# FDA Inspection 1067404 - Ionisos SAS - June 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/ionisos-sas/4d53bfbb-bacb-4596-917e-cb779fb4b9c9
Source feed: FDA_Inspections

> FDA Inspection 1067404 for Ionisos SAS on June 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1067404
- Company Name: Ionisos SAS
- Inspection Date: 2018-06-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1253949 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/ionisos-sas/570632e8-169c-442c-82c7-c196b76b214a)
- [FDA Inspection 1253949 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/ionisos-sas/31c70f4a-4f02-42e7-9314-14e194bcd005)
- [FDA Inspection 1253949 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/ionisos-sas/ca48a0a3-d0b1-457a-9193-5a6ad9a41d24)
- [FDA Inspection 1067404 - 2018-06-20](https://www.keypedia.com/records/fda_inspections/ionisos-sas/995ffbe9-ee8b-44a6-ac5d-c9a3288f82f0)

Company: https://www.keypedia.com/companies/ionisos-sas/923b562e-14d9-4b94-bfeb-c53d3baf0ae0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d